TGF-β signaling to chromatin: How Smads regulate transcription during self-renewal and differentiation

Seminars in Cell and Developmental Biology

Volumn 32, Issue , 2014, Pages 107-118

  Gaarenstroom, Tessa ^a   Hill, Caroline S ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Chromatin; Embryonic development; Embryonic stem cells; Smad; TGF superfamily; Transcription

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; POLYCOMB GROUP PROTEIN; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; CHROMATIN;

BINDING SITE; CELL DIFFERENTIATION; CELL TYPE; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; DEMETHYLATION; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE TARGETING; HUMAN; NONHUMAN; PROTEIN FUNCTION; REVIEW; ANIMAL; CELL PROLIFERATION; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN; EMBRYONIC STEM CELLS; HUMANS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84904463366     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.01.009     Document Type: Review

References (121)

1. Young R.A. Control of the embryonic stem cell state. Cell 2011, 144(6):940-954.
2. Fisher C.L., Fisher A.G. Chromatin states in pluripotent, differentiated, and reprogrammed cells. Curr Opin Genet Dev 2011, 21(2):140-146.
3. Adelman K., Lis J.T. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet 2012, 13(10):720-731.
4. Fuda N.J., Ardehali M.B., Lis J.T. Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature 2009, 461(7261):186-192.
5. Li B., Carey M., Workman J.L. The role of chromatin during transcription. Cell 2007, 128(4):707-719.
6. Ong C.-T., Corces V.G. Enhancers: emerging roles in cell fate specification. EMBO Rep 2012, 13(5):423-430.
7. Zhou V.W., Goren A., Bernstein B.E. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet 2011, 12(1):7-18.
8. Henikoff S., Shilatifard A. Histone modification: cause or cog?. Trends Genet 2011, 27(10):389-396.
9. Zentner G.E., Henikoff S. Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol 2013, 20(3):259-266.
10. Seila A.C., Calabrese J.M., Levine S.S., Yeo G.W., Rahl P.B., Flynn R.A., et al. Divergent transcription from active promoters. Science 2008, 322(5909):1849-1851.
11. Calo E., Wysocka J. Modification of enhancer chromatin: what, how, and why?. Mol Cell 2013, 49(5):825-837.
12. Rada-Iglesias A., Bajpai R., Swigut T., Brugmann S.A., Flynn R.A., Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011, 470(7333):279-283.
13. Buecker C., Wysocka J. Enhancers as information integration hubs in development: lessons from genomics. Trends Genet 2012, 28(6):276-284.
14. Spitz F., Furlong E.E.M. Transcription factors: from enhancer binding to developmental control. Nat Rev Genet 2012, 13(9):613-626.
15. Voss T.C., Schiltz R.L., Sung M.-H., Yen P.M., Stamatoyannopoulos J.A., Biddie S.C., et al. Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism. Cell 2011, 146(4):544-554.
16. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev 2011, 25(21):2227-2241.
17. Dillon N. Factor mediated gene priming in pluripotent stem cells sets the stage for lineage specification. Bioessays 2012, 34(3):194-204.
18. Levine M. Paused RNA polymerase II as a developmental checkpoint. Cell 2011, 145(4):502-511.
19. Voigt P., Tee W.W., Reinberg D. A double take on bivalent promoters. Genes Dev 2013, 27(12):1318-1338.
20. Klose R.J., Cooper S., Farcas A.M., Blackledge N.P., Brockdorff N. Chromatin sampling-an emerging perspective on targeting polycomb repressor proteins. PLoS Genet 2013, 9(8):e1003717.
21. Wu M.Y., Hill C.S. TGF-β superfamily signaling in embryonic development and homeostasis. Dev Cell 2009, 16(3):329-343.
22. Massague J. TGFβ signalling in context. Nat Rev Mol Cell Biol 2012, 13(10):616-630.
23. Schmierer B., Hill C.S. TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007, 8(12):970-982.
24. Moustakas A., Heldin C.-H. The regulation of TGFβ signal transduction. Development 2009, 136(22):3699-3714.
25. Mesnard D., Guzman-Ayala M., Constam D.B. Nodal specifies embryonic visceral endoderm and sustains pluripotent cells in the epiblast before overt axial patterning. Development 2006, 133(13):2497-2505.
26. Sui L., Bouwens L., Mfopou J.K. Signaling pathways during maintenance and definitive endoderm differentiation of embryonic stem cells. Int J Dev Biol 2013, 57(1):1-12.
27. Sulzbacher S., Schroeder I.S., Truong T.T., Wobus A.M. Activin A-induced differentiation of embryonic stem cells into endoderm and pancreatic progenitors-the influence of differentiation factors and culture conditions. Stem Cell Rev 2009, 5(2):159-173.
28. Willems E., Leyns L. Patterning of mouse embryonic stem cell-derived pan-mesoderm by Activin A/Nodal and Bmp4 signaling requires Fibroblast Growth Factor activity. Differentiation 2008, 76(7):745-759.
29. Brons I.G., Smithers L.E., Trotter M.W., Rugg-Gunn P., Sun B., Chuva de Sousa Lopes S.M., et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007, 448(7150):191-195.
30. Pauklin S., Pedersen R.A., Vallier L. Mouse pluripotent stem cells at a glance. J Cell Sci 2011, 124(Pt 22):3727-3732.
31. Galvin K.E., Travis E.D., Yee D., Magnuson T., Vivian J.L. Nodal signaling regulates the bone morphogenic protein pluripotency pathway in mouse embryonic stem cells. J Biol Chem 2010, 285(26):19747-19756.
32. Vallier L., Mendjan S., Brown S., Chng Z., Teo A., Smithers L.E., et al. Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development 2009, 136(8):1339-1349.
33. Dahle O., Kuehn M.R. Polycomb determines responses to smad2/3 signaling in embryonic stem cell differentiation and in reprogramming. Stem Cells 2013, 31(8):1488-1497.
34. Fei T., Zhu S., Xia K., Zhang J., Li Z., Han J.D., et al. Smad2 mediates Activin/Nodal signaling in mesendoderm differentiation of mouse embryonic stem cells. Cell Res 2010, 20(12):1306-1318.
35. Galvin-Burgess K.E., Travis E.D., Pierson K.E., Vivian J.L. TGF-β-superfamily signaling regulates embryonic stem cell heterogeneity: self-renewal as a dynamic and regulated equilibrium. Stem Cells 2013, 31(1):48-58.
36. Singh A.M., Reynolds D., Cliff T., Ohtsuka S., Mattheyses A.L., Sun Y., et al. Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell 2012, 10(3):312-326.
37. Avery S., Zafarana G., Gokhale P.J., Andrews P.W. The role of SMAD4 in human embryonic stem cell self-renewal and stem cell fate. Stem Cells 2010, 28(5):863-873.
38. Sakaki-Yumoto M., Liu J., Ramalho-Santos M., Yoshida N., Derynck R. Smad2 is essential for maintenance of the human and mouse primed pluripotent stem cell state. J Biol Chem 2013, 288(25):18546-18560.
39. Ross S., Hill C.S. How the Smads regulate transcription. Int J Biochem Cell Biol 2008, 40(3):383-408.
40. Alarcon C., Zaromytidou A.I., Xi Q., Gao S., Yu J., Fujisawa S., et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell 2009, 139(4):757-769.
41. Fuentealba L.C., Eivers E., Ikeda A., Hurtado C., Kuroda H., Pera E.M., et al. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 2007, 131(5):980-993.
42. Kretzschmar M., Doody J., Timokhina I., Massague J. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev 1999, 13(7):804-816.
43. Matsuura I., Denissova N.G., Wang G., He D., Long J., Liu F. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 2004, 430(6996):226-231.
44. Sapkota G., Alarcon C., Spagnoli F.M., Brivanlou A.H., Massague J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 2007, 25(3):441-454.
45. Gao S., Alarcon C., Sapkota G., Rahman S., Chen P.Y., Goerner N., et al. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-β signaling. Mol Cell 2009, 36(3):457-468.
46. Aragon E., Goerner N., Zaromytidou A.I., Xi Q., Escobedo A., Massague J., et al. A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev 2011, 25(12):1275-1288.
47. Hashiguchi M., Mullins M.C. Anteroposterior and dorsoventral patterning are coordinated by an identical patterning clock. Development 2013, 140(9):1970-1980.
48. Pauklin S., Vallier L. The cell-cycle state of stem cells determines cell fate propensity. Cell 2013, 155(1):135-147.
49. Tang L.Y., Yamashita M., Coussens N.P., Tang Y., Wang X., Li C., et al. Ablation of Smurf2 reveals an inhibition in TGF-β signalling through multiple mono-ubiquitination of Smad3. EMBO J 2011, 30(23):4777-4789.
50. Agricola E., Randall R.A., Gaarenstroom T., Dupont S., Hill C.S. Recruitment of TIF1γ to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities. Mol Cell 2011, 43(1):85-96.
51. Dupont S., Mamidi A., Cordenonsi M., Montagner M., Zacchigna L., Adorno M., et al. FAM/USP9x, a deubiquitinating enzyme essential for TGFβ signaling, controls Smad4 monoubiquitination. Cell 2009, 136(1):123-135.
52. Xi Q., Wang Z., Zaromytidou A.I., Zhang X.H., Chow-Tsang L.F., Liu J.X., et al. A poised chromatin platform for TGF-β access to master regulators. Cell 2011, 147(7):1511-1524.
53. Lonn P., van der Heide L.P., Dahl M., Hellman U., Heldin C.H., Moustakas A. PARP-1 attenuates Smad-mediated transcription. Mol Cell 2010, 40(4):521-532.
54. Heldin C.H., Moustakas A. Role of Smads in TGFβ signaling. Cell Tissue Res 2012, 347(1):21-36.
55. Miles W.O., Jaffray E., Campbell S.G., Takeda S., Bayston L.J., Basu S.P., et al. Medea SUMOylation restricts the signaling range of the Dpp morphogen in the Drosophila embryo. Genes Dev 2008, 22(18):2578-2590.
56. Shi Y., Wang Y.F., Jayaraman L., Yang H., Massague J., Pavletich N.P. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-β signaling. Cell 1998, 94(5):585-594.
57. Zawel L., Dai J.L., Buckhaults P., Zhou S., Kinzler K.W., Vogelstein B., et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1998, 1(4):611-617.
58. Gao S., Steffen J., Laughon A. Dpp-responsive silencers are bound by a trimeric Mad-Medea complex. J Biol Chem 2005, 280(43):36158-36164.
59. BabuRajendran N., Palasingam P., Narasimhan K., Sun W., Prabhakar S., Jauch R., et al. Structure of Smad1 MH1/DNA complex reveals distinctive rearrangements of BMP and TGF-β effectors. Nucleic Acids Res 2010, 38(10):3477-3488.
60. Pyrowolakis G., Hartmann B., Muller B., Basler K., Affolter M. A simple molecular complex mediates widespread BMP-induced repression during Drosophila development. Dev Cell 2004, 7(2):229-240.
61. Weiss A., Charbonnier E., Ellertsdottir E., Tsirigos A., Wolf C., Schuh R., et al. A conserved activation element in BMP signaling during Drosophila development. Nat Struct Mol Biol 2010, 17(1):69-76.
62. Affolter M., Basler K. The Decapentaplegic morphogen gradient: from pattern formation to growth regulation. Nat Rev Genet 2007, 8(9):663-674.
63. Blitz I.L., Cho K.W. Finding partners: how BMPs select their targets. Dev Dyn 2009, 238(6):1321-1331.
64. Javier A.L., Doan L.T., Luong M., Reyes de Mochel N.S., Sun A., Monuki E.S., et al. Bmp indicator mice reveal dynamic regulation of transcriptional response. PLoS ONE 2012, 7(9):e42566.
65. Yao L.C., Blitz I.L., Peiffer D.A., Phin S., Wang Y., Ogata S., et al. Schnurri transcription factors from Drosophila and vertebrates can mediate Bmp signaling through a phylogenetically conserved mechanism. Development 2006, 133(20):4025-4034.
66. Chen X., Rubock M.J., Whitman M. A transcriptional partner for MAD proteins in TGF-β signalling. Nature 1996, 383(6602):691-696.
67. Chen X., Weisberg E., Fridmacher V., Watanabe M., Naco G., Whitman M. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 1997, 389(6646):85-89.
68. Silvestri C., Narimatsu M., von Both I., Liu Y., Tan N.B., Izzi L., et al. Genome-wide identification of Smad/Foxh1 targets reveals a role for Foxh1 in retinoic acid regulation and forebrain development. Dev Cell 2008, 14(3):411-423.
69. Lenhart K.F., Holtzman N.G., Williams J.R., Burdine R.D. Integration of nodal and BMP signals in the heart requires FoxH1 to create left-right differences in cell migration rates that direct cardiac asymmetry. PLoS Genet 2013, 9(1):e1003109.
70. Yoon S.J., Wills A.E., Chuong E., Gupta R., Baker J.C. HEB and E2A function as SMAD/FOXH1 cofactors. Genes Dev 2011, 25(15):1654-1661.
71. Germain S., Howell M., Esslemont G.M., Hill C.S. Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. Genes Dev 2000, 14(4):435-451.
72. Randall R.A., Germain S., Inman G.J., Bates P.A., Hill C.S. Different Smad2 partners bind a common hydrophobic pocket in Smad2 via a defined proline-rich motif. EMBO J 2002, 21(1-2):145-156.
73. Kunwar P.S., Zimmerman S., Bennett J.T., Chen Y., Whitman M., Schier A.F. Mixer/Bon and FoxH1/Sur have overlapping and divergent roles in Nodal signaling and mesendoderm induction. Development 2003, 130(23):5589-5599.
74. Ross S., Cheung E., Petrakis T.G., Howell M., Kraus W.L., Hill C.S. Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription. EMBO J 2006, 25(19):4490-4502.
75. Guzman-Ayala M., Lee K.L., Mavrakis K.J., Goggolidou P., Norris D.P., Episkopou V. Graded Smad2/3 activation is converted directly into levels of target gene expression in embryonic stem cells. PLoS ONE 2009, 4(1):e4268.
76. Lee K.L., Lim S.K., Orlov Y.L., Yit le Y., Yang H., Ang L.T., et al. Graded Nodal/Activin signaling titrates conversion of quantitative phospho-Smad2 levels into qualitative embryonic stem cell fate decisions. PLoS Genet 2011, 7(6):e1002130.
77. Brown S., Teo A., Pauklin S., Hannan N., Cho C.H.H., Lim B., et al. Activin/Nodal signaling controls divergent transcriptional networks in human embryonic stem cells and in endoderm progenitors. Stem Cells 2011, 29(8):1176-1185.
78. Fei T., Xia K., Li Z., Zhou B., Zhu S., Chen H., et al. Genome-wide mapping of SMAD target genes reveals the role of BMP signaling in embryonic stem cell fate determination. Genome Res 2010, 20(1):36-44.
79. Koinuma D., Tsutsumi S., Kamimura N., Imamura T., Aburatani H., Miyazono K. Promoter-wide analysis of Smad4 binding sites in human epithelial cells. Cancer Sci 2009, 100(11):2133-2142.
80. Koinuma D., Tsutsumi S., Kamimura N., Taniguchi H., Miyazawa K., Sunamura M., et al. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor β signaling. Mol Cell Biol 2009, 29(1):172-186.
81. Liu Z., Lin X., Cai Z., Zhang Z., Han C., Jia S., et al. Global identification of SMAD2 target genes reveals a role for multiple co-regulatory factors in zebrafish early gastrulas. J Biol Chem 2011, 286(32):28520-28532.
82. Mizutani A., Koinuma D., Tsutsumi S., Kamimura N., Morikawa M., Suzuki H.I., et al. Cell type-specific target selection by combinatorial binding of Smad2/3 proteins and hepatocyte nuclear factor 4 in HepG2 cells. J Biol Chem 2011, 286(34):29848-29860.
83. Morikawa M., Koinuma D., Tsutsumi S., Vasilaki E., Kanki Y., Heldin C.H., et al. ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res 2011, 39(20):8712-8727.
84. Mullen A.C., Orlando D.A., Newman J.J., Loven J., Kumar R.M., Bilodeau S., et al. Master transcription factors determine cell-type-specific responses to TGF-β signaling. Cell 2011, 147(3):565-576.
85. Qin H., Chan M.W.Y., Liyanarachchi S., Balch C., Potter D., Souriraj I.J., et al. An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules. BMC Syst Biol 2009, 3:73.
86. Trompouki E., Bowman T.V., Lawton L.N., Fan Z.P., Wu D.C., DiBiase A., et al. Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell 2011, 147(3):577-589.
87. Postigo A.A., Depp J.L., Taylor J.J., Kroll K.L. Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J 2003, 22(10):2453-2462.
88. Postigo A.A. Opposing functions of ZEB proteins in the regulation of the TGFβ/BMP signaling pathway. EMBO J 2003, 22(10):2443-2452.
89. Chng Z., Teo A., Pedersen R.A., Vallier L. SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells. Stem Cell 2010, 6(1):59-70.
90. Luo K. Ski and SnoN: negative regulators of TGF-β signaling. Curr Opin Genet Dev 2004, 14(1):65-70.
91. Levy L., Howell M., Das D., Harkin S., Episkopou V., Hill C.S. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol 2007, 27(17):6068-6083.
92. Deheuninck J., Luo K. Ski and SnoN, potent negative regulators of TGF-β signaling. Cell Res 2009, 19(1):47-57.
93. Le Scolan E., Zhu Q., Wang L., Bandyopadhyay A., Javelaud D., Mauviel A., et al. Transforming growth factor-β suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. Cancer Res 2008, 68(9):3277-3285.
94. Tsuneyoshi N., Tan E.K., Sadasivam A., Poobalan Y., Sumi T., Nakatsuji N., et al. The SMAD2/3 corepressor SNON maintains pluripotency through selective repression of mesendodermal genes in human ES cells. Genes Dev 2012, 26(22):2471-2476.
95. Massague J., Xi Q. TGF-β control of stem cell differentiation genes. FEBS Lett 2012, 586(14):1953-1958.
96. Kang Y., Chen C.R., Massague J. A self-enabling TGFβ response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell 2003, 11(4):915-926.
97. Cloos P.A.C., Christensen J., Agger K., Helin K. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev 2008, 22(9):1115-1140.
98. Kim S.W., Yoon S.J., Chuong E., Oyolu C., Wills A.E., Gupta R., et al. Chromatin and transcriptional signatures for Nodal signaling during endoderm formation in hESCs. Dev Biol 2011, 357(2):492-504.
99. Dahle O., Kumar A., Kuehn M.R. Nodal signaling recruits the histone demethylase Jmjd3 to counteract polycomb-mediated repression at target genes. Sci Signal 2010, 3(127):ra48.
100. Estaras C., Akizu N., Garcia A., Beltran S., de la Cruz X., Martinez-Balbas M.A. Genome-wide analysis reveals that Smad3 and JMJD3 HDM co-activate the neural developmental program. Development 2012, 139(15):2681-2691.
101. Akizu N., Estaras C., Guerrero L., Marti E., Martinez-Balbas M.A. H3K27me3 regulates BMP activity in developing spinal cord. Development 2010, 137(17):2915-2925.
102. Attisano L., Wrana J.L. Signal integration in TGF-β, WNT, and Hippo pathways. F1000Prime Rep 2013, 5:17.
103. Hussein S.M., Duff E.K., Sirard C. Smad4 and β-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 2003, 278(49):48805-48814.
104. Varelas X., Sakuma R., Samavarchi-Tehrani P., Peerani R., Rao B.M., Dembowy J., et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 2008, 10(7):837-848.
105. Feng X.H., Zhang Y., Wu R.Y., Derynck R. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-β-induced transcriptional activation. Genes Dev 1998, 12(14):2153-2163.
106. Janknecht R., Wells N.J., Hunter T. TGF-β-stimulated cooperation of smad proteins with the coactivators CBP/p300. Genes Dev 1998, 12(14):2114-2119.
107. Kato Y., Habas R., Katsuyama Y., Naar A.M., He X. A component of the ARC/Mediator complex required for TGF β/Nodal signalling. Nature 2002, 418(6898):641-646.
108. Xi Q., He W., Zhang X.H., Le H.V., Massague J. Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor β transcriptional program. J Biol Chem 2008, 283(2):1146-1155.
109. Ho L., Jothi R., Ronan J.L., Cui K., Zhao K., Crabtree G.R. An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci USA 2009, 106(13):5187-5191.
110. Ho L., Ronan J.L., Wu J., Staahl B.T., Chen L., Kuo A., et al. An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc Natl Acad Sci USA 2009, 106(13):5181-5186.
111. Ho L., Miller E.L., Ronan J.L., Ho W.Q., Jothi R., Crabtree G.R. esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function. Nat Cell Biol 2011, 13(8):903-913.
112. Landry J., Sharov A.A., Piao Y., Sharova L.V., Xiao H., Southon E., et al. Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells. PLoS Genet 2008, 4(10):e1000241.
113. Chen X., Xu H., Yuan P., Fang F., Huss M., Vega V.B., et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133(6):1106-1117.
114. Lee M.T., Bonneau A.R., Takacs C.M., Bazzini A.A., Divito K.R., Fleming E.S., et al. Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition. Nature 2013, 503(7476):360-364.
115. Leichsenring M., Maes J., Mossner R., Driever W., Onichtchouk D. Pou5f1 transcription factor controls zygotic gene activation in vertebrates. Science 2013, 341(6149):1005-1009.
116. Liu D., Black B.L., Derynck R. TGF-β inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev 2001, 15(22):2950-2966.
117. Teo A.K.K., Arnold S.J., Trotter M.W.B., Brown S., Ang L.T., Chng Z., et al. Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev 2011, 25(3):238-250.
118. Ding N., Yu R.T., Subramaniam N., Sherman M.H., Wilson C., Rao R., et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 2013, 153(3):601-613.
119. Vallier L., Touboul T., Brown S., Cho C., Bilican B., Alexander M., et al. Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem Cells 2009, 27(11):2655-2666.
120. Gomis R.R., Alarcon C., He W., Wang Q., Seoane J., Lash A., et al. A FoxO-Smad synexpression group in human keratinocytes. Proc Natl Acad Sci U S A 2006, 103(34):12747-12752.
121. Ikushima H., Komuro A., Isogaya K., Shinozaki M., Hellman U., Miyazawa K., et al. An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-β signalling. EMBO J 2008, 27(22):2955-2965.